A team of Harvard researchers have unveiled a way to map the molecular underpinnings of how learning and memories are formed, ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase I/II study investigating lead ...

SMA Europe's 1st International Clinical Care Symposium on SMA will focus on disease symptoms that may lead to ...